Ito K - Search Results

1

Inhibitory effects of daiokanzoto (da-huang-gan-cao-tang) on p-glycoprotein.

Watanabe Y, Ikarashi N, Satoh T, Ito K, Ochiai W, Sugiyama K. Watanabe Y, et al. Among authors: ito k. Evid Based Complement Alternat Med. 2012;2012:361516. doi: 10.1155/2012/361516. Epub 2012 Aug 27. Evid Based Complement Alternat Med. 2012. PMID: 22969825 Free PMC article.

2

Effects of Kampo medicines on CYP and P-gp activity in vitro.

Ito K, Satoh T, Watanabe Y, Ikarashi N, Asano T, Morita T, Sugiyama K. Ito K, et al. Biol Pharm Bull. 2008 May;31(5):893-6. doi: 10.1248/bpb.31.893. Biol Pharm Bull. 2008. PMID: 18451514 Free article.

3

Delayed neonatal closure of the ductus arteriosus following early in utero exposure to indomethacin in the rat.

Momma K, Toyoshima K, Ito K, Sugiyama K, Imamura S, Sun F, Nakanishi T. Momma K, et al. Among authors: ito k. Neonatology. 2009;96(2):69-79. doi: 10.1159/000203336. Epub 2009 Feb 19. Neonatology. 2009. PMID: 19225238

4

Effect of hydrocotarnine on cytochrome P450 and P-glycoprotein.

Ito K, Kubota Y, Toda T, Suto S, Ikarashi N, Sugiyama K. Ito K, et al. Drug Metab Pharmacokinet. 2009;24(1):108-13. doi: 10.2133/dmpk.24.108. Drug Metab Pharmacokinet. 2009. PMID: 19252340 Free article.

5

Intestinal flora induces the expression of Cyp3a in the mouse liver.

Toda T, Saito N, Ikarashi N, Ito K, Yamamoto M, Ishige A, Watanabe K, Sugiyama K. Toda T, et al. Among authors: ito k. Xenobiotica. 2009 Apr;39(4):323-34. doi: 10.1080/00498250802651984. Xenobiotica. 2009. PMID: 19350455

6

Prediction of human bioavailability from human oral administration data and animal pharmacokinetic data without data from intravenous administration of drugs in humans.

Imawaka H, Ito K, Kitamura Y, Sugiyama K, Sugiyama Y. Imawaka H, et al. Among authors: ito k. Pharm Res. 2009 Aug;26(8):1881-9. doi: 10.1007/s11095-009-9902-6. Epub 2009 May 7. Pharm Res. 2009. PMID: 19418207

7

[Antibiotics suppress Cyp3a in the mouse liver by reducing lithocholic acid-producing intestinal flora].

Toda T, Ohi K, Kudo T, Yoshida T, Ikarashi N, Ito K, Sugiyama K. Toda T, et al. Among authors: ito k. Yakugaku Zasshi. 2009 May;129(5):601-8. doi: 10.1248/yakushi.129.601. Yakugaku Zasshi. 2009. PMID: 19420891 Free article. Japanese.

8

Ciprofloxacin suppresses Cyp3a in mouse liver by reducing lithocholic acid-producing intestinal flora.

Toda T, Ohi K, Kudo T, Yoshida T, Ikarashi N, Ito K, Sugiyama K. Toda T, et al. Among authors: ito k. Drug Metab Pharmacokinet. 2009;24(3):201-8. doi: 10.2133/dmpk.24.201. Drug Metab Pharmacokinet. 2009. PMID: 19571431 Free article.

9

Altered expression of CYP in TSOD mice: a model of type 2 diabetes and obesity.

Kudo T, Shimada T, Toda T, Igeta S, Suzuki W, Ikarashi N, Ochiai W, Ito K, Aburada M, Sugiyama K. Kudo T, et al. Among authors: ito k. Xenobiotica. 2009 Dec;39(12):889-902. doi: 10.3109/00498250903242592. Xenobiotica. 2009. PMID: 19925381

10

Disposition of a new tamibarotene prodrug in mice.

Sugitani M, Abe R, Ikarashi N, Ito K, Muratake H, Shudo K, Sugiyama K. Sugitani M, et al. Among authors: ito k. Biol Pharm Bull. 2009 Dec;32(12):1997-2001. doi: 10.1248/bpb.32.1997. Biol Pharm Bull. 2009. PMID: 19952418 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,886 results

Search Page